pSivida Corp - PSDV - reported the positive outcome of the Decentralized Procedure for the approval of ILUVIEN in Europe. JA Solar Holdings Co. Ltd - JASO - announced that shipments for the Q4 of 2011 are expected to be in the range of 390 to 410 megawatts, exceeding the Company’s previously provided shipment guidance of 310 to 330 megawatts. Coronado Biosciences Inc - CNDO - reported positive results from the Phase 1 clinical trial of TSO (Trichuris suis ova or CNDO-201) in patients with Crohn’s disease. According to the company, the study showed that TSO is safe and well tolerated ***** THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://www.crwenewswire.com/disclaimer)
投稿者: karmastock
投稿日時:2012-02-29 04:55:28.0
視聴回数:427回
お気に入り登録:0
カテゴリ:
ビジネス全般
タグ:
PSDV
JASO
CNDO
Nasdaq:PSDV
Nasdaq:JASO
Nasdaq:CNDO